Bombay High Court says domestic laws apply to duty-free shops
The Bombay High Court has ruled that goods sold at duty-free shops are not immune from domestic laws. Gautam Adani in April challenged authorities who said his group's Mumbai international airport shops illegally stocked and sold nicotine pouches, which remain unapproved in India. The court rejected the argument that shops in international departure areas lie beyond India's territorial jurisdiction. Adani Group denied any wrongdoing. The order was issued on September 22.
Source
The Hindu — Business · read the original report ↗
Desk check · compared with the source
What the desk checked (5)
- Bombay High Court ruled goods sold at duty-free shops are not immune from domestic laws. — Directly quoted from the order issued late Tuesday, September 22, 2026, as reported in the source.
- Adani Group's Mumbai international airport shops illegally stocked and sold nicotine pouches unapproved in India. — Allegation attributed to Indian authorities/the Centre; Adani denied wrongdoing.
- Adani argued international departure area shops lie beyond India's territorial jurisdiction. — Attributed to Adani's court submissions; rejected by the court.
- Adani Group manages eight airports in India and has an $11 billion expansion plan. — Figures appear in the source with no independent attribution given.
- Adani Group did not respond to requests for comment. — Attributed to Reuters; no company statement available.
Analysts’ view opinion
The economic significance of this ruling lies in raising the regulatory risk attached to the duty-free business model. By holding that domestic law applies even to transactions beyond the customs barrier, the court narrows what airport retailers can stock and pushes up compliance costs. That matters for a group that runs eight Indian airports and has an $11 billion expansion plan including duty-free shops — though this is a decision about one high-margin product category, not a bar on the business itself.
- Duty-free is a high-margin revenue line in airport retail, so clarifying that domestic regulation applies can compress product range and pressure revenue per passenger.
- Because the case is widely seen as setting a precedent, the impact likely extends beyond Adani to the wider Indian duty-free chain, suppliers and brands.
- Who pays: operators absorb compliance, inventory review and legal costs; on the other side, the government's case is that tighter enforcement reduces public-health risk and its associated costs.
- Duty-free earnings are only one component of the $11 billion expansion plan, with rising passenger traffic likely remaining the main growth driver.
- By leaving open whether nicotine pouches count as a drug and sending the question to the regulator, the court preserves commercial uncertainty for some time.
What to watch — Watch whether the Adani Group takes the question to India's drug regulator, and whether other airport retailers pre-emptively adjust what they stock.
The story does not establish the size of any financial hit, how much of duty-free revenue this category represents, or what penalties or appeal options follow — and the Adani Group did not immediately comment.
Deep dive
Research brief · 8 facts · 3 dates · exam-readyThe brief
Context
Duty-free shops (DFS) at international airports sit beyond the customs barrier, and operators have long argued that sales there escape domestic regulation. The Adani Group, which runs Mumbai international airport's duty-free outlets, was told by Indian authorities that its shops illegally stocked and sold nicotine pouches — a product not approved in India and treated by the Centre as a drug. Adani challenged the authorities in the Bombay High Court in April, arguing that international departure areas lie outside India's territorial jurisdiction. The High Court rejected that argument in an order issued late on Tuesday, September 22, 2026.
Key facts
- The Bombay High Court ruled that goods sold at duty-free shops are not immune from domestic laws; the order was issued late Tuesday, September 22, 2026.
- The order said such goods are subject to the law of the land "even if the transaction takes place in the DFS, beyond the customs barrier".
- Gautam Adani challenged Indian authorities in April over the charge that his group's Mumbai international airport shops illegally stocked and sold nicotine pouches.
- Nicotine pouches remain unapproved in India; the Centre calls their sale illegal and regards them as drugs.
- Authorities told the court that stocking nicotine pouches was a "substantive violation" of drug laws and a "serious public health risk".
- Adani argued in court that nicotine pouches are "not a drug" and a "recent innovation" attracting no scrutiny under Indian laws; New Delhi disagreed.
- The court declined to decide whether nicotine pouches are a drug at this stage, leaving Adani free to make representations before Indian drug regulators.
- The Adani Group manages eight airports in India and has an $11 billion expansion plan, including duty-free shops.
Timeline
- April (year as per the case, per source)Gautam Adani challenges Indian authorities who said his group's Mumbai international airport shops illegally stocked and sold nicotine pouches.
- September 22, 2026 (late Tuesday)Bombay High Court issues order holding that the domestic regulatory regime applies in full force to goods brought into duty-free shops within Indian territorial jurisdiction.
- September 23, 2026Report on the ruling published.
Who has a stake
- Adani Group / Gautam Adani — Operates duty-free shops at Mumbai international airport and manages eight Indian airports with an $11 billion expansion plan; faces regulatory exposure on nicotine pouch sales.
- Bombay High Court — Decided the jurisdictional question, holding duty-free sales beyond the customs barrier are still governed by Indian law.
- The Centre / Indian authorities — Argued stocking nicotine pouches was a substantive violation of drug laws and a serious public health risk.
- Indian drug regulators — Will decide on merits, if Adani makes representations with supporting material, whether nicotine pouches fall under drug regulation.
- Duty-free retail industry and airport operators — The case is widely seen as setting a precedent on duty-free sales and the reach of domestic regulation.
- Air travellers and public health — Access to nicotine pouches, described as one of the world's fastest-growing nicotine products, at international departure areas.
Why it matters
The ruling closes a long-claimed regulatory grey zone by confirming that being beyond the customs barrier does not place duty-free shops beyond Indian law. It has direct commercial implications for airport retail, including the Adani Group's $11 billion airport expansion plan covering duty-free shops. It also strengthens the Centre's public health position on unapproved nicotine products sold at international terminals.
UPSC angle
Prelims pointers
- Bombay High Court order of September 22, 2026: goods in duty-free shops are subject to the law of the land even beyond the customs barrier.
- Nicotine pouches are unapproved in India and are regarded by the Centre as drugs.
- Adani Group manages eight airports in India and has an $11 billion airport expansion plan including duty-free shops.
- DFS stands for duty-free shops, located beyond the customs barrier at international airports.
- The court left the question of whether nicotine pouches are a "drug" to Indian drug regulators to decide on merits.
- Adani's core legal plea — that international departure areas lie beyond India's territorial jurisdiction — was rejected.
Mains framing
The dispute arose from a jurisdictional claim long implicit in duty-free retail: that shops in international departure areas, lying beyond the customs barrier, are outside the reach of domestic regulation. The Bombay High Court rejected this, holding that goods brought into duty-free shops within Indian territorial jurisdiction remain governed by the regulatory regime in force, regardless of where the transaction occurs. The immediate trigger was the Centre's position that nicotine pouches — unapproved in India and treated as drugs — were being illegally stocked and sold at Mumbai international airport, which authorities described as a "substantive violation" of drug laws and a "serious public health risk"; Adani denied wrongdoing and argued the pouches are a "recent innovation" and "not a drug". The implications run in two directions: regulatory certainty and public health enforcement at airports on one side, and compliance costs and product-range constraints for a fast-expanding airport retail business on the other, given the group's eight airports and $11 billion expansion plan. The court's own way forward is procedural rather than substantive — it declined to classify nicotine pouches at this stage and directed the company to make representations with supporting material before Indian drug regulators, who must decide on merits. This leaves the substantive product-classification question to expert regulatory determination while settling the jurisdictional principle.
Key terms
- Duty-free shop (DFS)
- Retail outlet at an international airport, located beyond the customs barrier, selling goods without certain domestic duties.
- Customs barrier
- The notional line at an airport or port beyond which goods are treated as not yet cleared for domestic consumption.
- Nicotine pouches
- Oral nicotine products described in the source as one of the world's fastest-growing nicotine products; unapproved in India.
- Territorial jurisdiction
- The geographic area over which a state's laws apply; Adani argued departure areas fell outside it, and the court disagreed.
- Indian drug regulators
- Authorities before whom Adani may make representations on whether nicotine pouches qualify as a drug, to be decided on merits.
Practice questions
- Critically examine the Bombay High Court's position that goods sold in duty-free shops beyond the customs barrier remain subject to the domestic regulatory regime. What are its implications for airport retail in India?
- Should the classification of novel nicotine products be settled by courts or by expert drug regulators? Discuss with reference to the Bombay High Court's September 2026 order.
- Discuss the tension between promoting airport infrastructure and duty-free commerce and enforcing public health regulation on unapproved nicotine products.
Grounded only in the source report — figures and dates are the source's, not inferred.